跳至主要内容
临床试验/IRCT201506181165N5
IRCT201506181165N5已完成未知

Assessment of efficacy and safety of Iranian version of NAC and comparing it with foreign sample of NAC in controlling pulmonary symptoms caused by sulfur mustard in chemically-wounded patients and veterans

Research deputy of Baqiyatallah University of Medical Sciences0 个研究点目标入组 84 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
84

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • documented exposure to sulfur mustard; documented diagnosis of chronic pulmonary disease due to mustard gas (histological evidence from previous biopsies); no history of tuberculosis; no history of resection of one or more lobes of lung
  • Exclusion criteria: pneumonia; acute bronchitis; smoking cigarettes; being a substance abuser; any illness in which the medications could not be stopped; occurrence of any severe side effects of N-acetylcysteine (anaphylactoid reaction); use of any kind of antioxidant drugs; deterioration of clinical conditions during the course of the study; consuming less than 80% of allocated NAC medication

排除标准

  • 未提供

研究者

发起方
Research deputy of Baqiyatallah University of Medical Sciences

相似试验